Who are medical cannabis's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Single-dose of cannabis oil, THC/CBD.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/medical-cannabis.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

medical cannabis — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

medical cannabis (medical cannabis) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pain management, Nausea and vomiting, Muscle spasms.

phase 3 CB1 and CB2 receptors Pain management, Nausea and vomiting, Muscle spasms Small molecule Live · refreshed every 30 min

Target snapshot

medical cannabis (medical cannabis) — HaEmek Medical Center, Israel. Medical cannabis exerts its effects through the body's endocannabinoid system, influencing various physiological processes.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
medical cannabis TARGET	medical cannabis	HaEmek Medical Center, Israel	phase 3		CB1 and CB2 receptors
Single-dose of cannabis oil	Single-dose of cannabis oil	Hadassah Medical Organization	phase 3		CB1 and CB2 receptors
THC/CBD	THC/CBD	Azienda Ospedaliera Universitaria Policlinico "G. Martino"	phase 3	cannabinoid	CB1 and CB2 receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). medical cannabis — Competitive Intelligence Brief. https://druglandscape.com/ci/medical-cannabis. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab